Assignee
CHEMGENEX PHARMACEUTICALS INC
AU·4 granted patents·12 pending applications·7 citations·filing 2003–2017
Top patents by PatentIndex Score
16 records- 0185US7683050B2Formulations and methods of administration of cephalotaxines, including homoharringtonineCHEMGENEX PHARMACEUTICALS INC·Filed 2006·Granted Mar 23, 2010·3 cites·14 claims
- 0278US7842687B2Cephalotaxane derivatives and their processes of preparation and purificationCHEMGENEX PHARMACEUTICALS INC·Filed 2006·Granted Nov 30, 2010·3 cites·29 claims
- 0364US2015104416A1Leukemic Stem Cell AblationCHEMGENEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0463US7642252B2Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereofCHEMGENEX PHARMACEUTICALS INC·Filed 2003·Granted Jan 5, 2010·1 cites·22 claims
- 0561US7135481B2Naphthalimide compositions and uses thereofCHEMGENEX PHARMACEUTICALS INC·Filed 2005·Granted Nov 14, 2006·0 cites·13 claims
- 0660US2009270368A1Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereofCHEMGENEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0759US2011008307A1Cephalotaxine Alkaloid Compositions and Uses ThereofCHEMGENEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 0858US2017319640A1Formulations and Methods of Administration of Cephalotaxines, Including HomoharringtonineCHEMGENEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0958US2009068236A1Oral Cephalotaxine Dosage FormsCHEMGENEX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1057US2009176759A1Leukemic stem cell ablationCHEMGENEX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1153US2006211648A1Naphthalimide compositions and uses thereofCHEMGENEX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1251US2011262383A1Naphthalimide Dosing by N-Acetyl Transferase GenotypingCHEMGENEX PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 1349US2006193893A1Medical devicesCHEMGENEX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1448US2011003742A1Naphthalimide Dosing by N-Acetyl Transferase GenotypingCHEMGENEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1547US2016193223A1Oral cephalotaxine dosage formsCHEMGENEX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1642US2005288310A1Methods of treating cellular proliferative disease using naphthalimide and PARP-1 inhibitorsCHEMGENEX PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →